Cargando…
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
B-cell lymphoma 2 (BCL-2) family proteins primarily work as a programmed cell death regulator, whereby multiple interactions between them determine cell survival. This explains the two major classes of BCL-2 proteins which are anti-apoptotic and pro-apoptotic proteins. The anti-apoptotic proteins ar...
Autores principales: | Mohamad Anuar, Nur Najmi, Nor Hisam, Nur Syahidah, Liew, Sze Ling, Ugusman, Azizah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768911/ https://www.ncbi.nlm.nih.gov/pubmed/33381025 http://dx.doi.org/10.3389/fphar.2020.564108 |
Ejemplares similares
-
Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence
por: Nor Hisam, Nur Syahidah, et al.
Publicado: (2021) -
Evaluating the Potential of Plukenetia volubilis Linneo (Sacha Inchi) in Alleviating Cardiovascular Disease Risk Factors: A Mini Review
por: Abd Rahman, Izzat Zulhilmi, et al.
Publicado: (2023) -
Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
por: Zhu, Yi, et al.
Publicado: (2016) -
Exploring the Relationship of Perivascular Adipose Tissue Inflammation and the Development of Vascular Pathologies
por: Rami, Afifah Zahirah Abd, et al.
Publicado: (2022) -
Effects of Piper sarmentosum Roxb. on hypertension and diabetes mellitus: A systematic review and meta-analysis
por: Othman, Nur Syakirah, et al.
Publicado: (2022)